Island Pharmaceuticals (ASX:ILA) has confirmed that the US Food and Drug Administration will provide formal feedback on its antiviral candidate Galidesivir by 12 November 202, despite recent government shutdowns in the United States. …
Island Pharmaceuticals secures FDA response date for Galidesivir approval pathway
October 23, 2025 Australian Biotech
Latest Video
New Stories
-
Omico appoints Richard Vines as new Chair as it strengthens national precision oncology agenda
October 23, 2025 - - Latest News -
Island Pharmaceuticals secures FDA response date for Galidesivir approval pathway
October 23, 2025 - - Australian Biotech -
Noxopharm granted first US patent for Sofra immune-modulation platform
October 23, 2025 - - Australian Biotech -
4DMedical secures Stanford as first commercial site and expands AstraZeneca partnership in Brazil
October 23, 2025 - - Australian Biotech -
ImpediMed accelerates growth strategy on strong results and expanding market reach
October 23, 2025 - - Australian Biotech -
Clarity Pharmaceuticals’ copper theranostics platform delivers superior prostate cancer imaging results
October 23, 2025 - - Australian Biotech -
Starpharma receives upfront payment from Genentech, launching oncology collaboration
October 23, 2025 - - Australian Biotech